Abstract
Excessive sweating is a well-known side effect of a selective serotonin reuptake inhibitor treatment, but little is known about the impact of sweating on treatment discontinuation or the general quality of life of patients. In this case report, we present a patient suffering from excessive sweating induced by escitalopram. When mirtazapine was administered as an additional treatment, a dose-dependent reduction of drug-induced excessive sweating was observed. Taking into account the particular serotonin antagonistic properties of mirtazapine, its eventual influence on the regulation of body temperature and diaphoresis in the central nervous system is discussed.
Similar content being viewed by others
References
Nelson JC (1997) Safety and tolerability of the new antidepressants. J Clin Psychiatry 58(Suppl 6):26–31
Pierre JM, Guze BH (2000) Benztropine for venlafaxine-induced night sweats. J Clin Psychopharmacol 20(2):269
Garber A, Gregory RJ (1997) Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry 58(4):176–177
Feder R (1995) Clonidine treatment of excessive sweating. J Clin Psychiatry 56(1):35
Ashton AK, Weinstein WL (2002) Cyproheptadine for drug-induced sweating. Am J Psychiatry 159(5):874–875
Stahl SM (1997) Psychopharmacology of antidepressants. Martin Dunitz Ltd., London
Sugimoto Y, Ohkura M, Inoue K, Yamada J (2001) Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice. Eur J Pharmacol 430(2–3):265–268
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buecking, A., Vandeleur, C.L., Khazaal, Y. et al. Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol 61, 543–544 (2005). https://doi.org/10.1007/s00228-005-0956-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0956-z